Antengene announces xpovio® (selinexor) approved for commercialization in malaysia

Xpovio® is the first and only approved xpo1 inhibitor in malaysia. xpovio® has been approved for multiple indications in eight markets across the apac region.

KPTI Ratings Summary

KPTI Quant Ranking